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AbstrACt
Introduction Controversy exists about the optimal 
treatment for patients with a traumatic acute subdural 
haematoma (ASDH) and an intracerebral haematoma/
contusion (t-ICH). Treatment varies largely between 
different regions. The effect of this practice variation 
on patient outcome is unknown. Here, we present the 
protocol for a prospective multicentre observational 
study aimed at comparing the effectiveness of different 
treatment strategies in patients with ASDH and/or t-ICH. 
Specifically, the aims are to compare (1) an acute surgical 
approach to an expectant approach and (2) craniotomy 
to decompressive craniectomy when evacuating the 
haematoma.
Methods and analysis Patients presenting to the 
emergency room with an ASDH and/or an t-ICH are eligible 
for inclusion. Standardised prospective data on patient 
and injury characteristics, treatment and outcome will be 
collected on 1000 ASDH and 750 t-ICH patients in 60–70 
centres within two multicentre prospective observational 
cohort studies: the Collaborative European NeuroTrauma 
Effectiveness Research in Traumatic Brain Injury (CENTER-
TBI) and Neurotraumatology Quality Registry (Net-QuRe). 
The interventions of interest are acute surgery, defined as 
surgery directly after the first CT at presentation versus 
late or no surgery and craniotomy versus decompressive 
craniectomy. The primary outcome measure is the Glasgow 
Outcome Score-Extended at 6 months. Secondary outcome 
measures include in-hospital mortality, quality of life and 
neuropsychological tests. In the primary analysis, the effect 
of treatment preference (eg, proportion of patients in which 
the intervention under study is preferred) per hospital 
will be analysed with random effects ordinal regression 
models, adjusted for casemix and stratified by study. Such 
a hospital-level approach reduces confounding by the 
indication. Sensitivity analyses will include propensity score 
matching, with treatment defined on patient level. This 
study is designed to determine the best acute management 
strategy for ASDH and t-ICH by exploiting the existing 
between-hospital variability in surgical management.
Ethics and dissemination Ethics approval was 
obtained in all participating countries. Results of surgical 
management of ASDH and t-ICH/contusion will separately 
be submitted for publication in a peer-reviewed journal.
trial registration number NCT02210221 and NL 5761.
bACkground
In Europe, over two million patients are 
admitted to hospital each year for traumatic 
brain injury (TBI), of whom 82 000 people 
die.1 Survivors may have long-term physical, 
cognitive and mental disorders that often 
necessitate specialised care or rehabilitation 
programme. This debilitating morbidity has 
been estimated to lead to enormous societal 
costs.2 An acute intracranial haematoma is 
strengths and limitations of this study
 ► This comparative effectiveness study is a multi-
centre prospective observational cohort study that 
exploits variation in management strategies for in-
tracranial haematomas to enable comparisons of 
the effectiveness of interventions.
 ► To overcome the bias by confounding the main 
analyses uses an instrumental variable approach; 
this approach is more robust to address unmea-
sured confounding than conventional individual pa-
tients-level analysis methods.
 ► Large sample sizes will be recruited: 1000 patients 
with acute subdural haematoma and 750 patients 
with intracerebral haematoma/contusion are ex-
pected, recruited in approximately 70 centres.
 ► Simulation studies confirmed the expected samples 
to be sufficient.
 ► The main limitation of this study is the absence of a 
randomised assignment of treatment strategy.
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Figure 1 Different types of post-traumatic intracranial haematoma. (A) Epidural haematoma: a collection of blood between 
the skull and the outer membrane covering the brain (dura mater). (B) Subdural haematoma: a collection of blood located 
underneath the dura mater, generally associated with bruising of the underlying brain tissue (contusions). (C) Haemorrhagic 
contusion and intracerebral haematoma: lesions that reflect similar underlying pathologies, ranging from local bruising 
(contusions) to bleeding into the brain tissue (haematoma). Figure courtesy of Maartje Kunen, Medical Visuals, Arnhem, 
Netherlands. Reproduced with permission from Maas et al.48
the most frequently encountered pathological entity in 
patients with TBI (figure 1). Predominantly two specific 
subtypes, the acute subdural and an intracerebral 
haematoma or contusion (ASDH and t-ICH), occur in, 
respectively, 11% and 8% of all patients with moderate 
TBI and up to 49% and 35% of all patients with severe 
TBI.3–6 Patients with an ASDH and/or t-ICH can show 
a wide array of symptoms, ranging from relatively mild 
complaints such as headache and nausea to severe condi-
tions such as a comatose state (defined by a Glasgow 
Coma Scale (GCS) <9).
Management of these traumatic haematomas can 
be challenging and requires the integration of clinical 
findings and diagnostic imaging. The main question is 
whether or not the patient needs to be immediately oper-
ated on for evacuation of the haematoma and, second, 
if this surgical evacuation should be accompanied by a 
decompressive craniectomy (DC, ie, leaving the bone flap 
out) or not.
Among comatose patients with a large ASDH, direct 
evacuation of the haematoma leads to a lower mortality.3 4 
Although questioning the effectiveness of surgery in these 
patients has been compared with questioning the effec-
tiveness of a parachute in skydiving,5 6 this cannot be 
generalised to most ASDH patients. Surgery may save a 
patient’s life and preserve neurological function, some, 
however, may have an unsatisfactory functional outcome, 
ranging from severe neurological and cognitive deficits 
to a persistent vegetative state.7–9 Furthermore, certain 
subgroups may not benefit from surgery because the 
damage by the primary injury is simply too devastating.9 
On the other hand, surgery may not always be necessary 
and a substantial proportion of patients managed conser-
vatively have satisfactory outcomes.10–14 In addition, 
timing of surgery plays a role, specifically for a t-ICH. 
Sometimes a t-ICH is initially managed conservatively, 
but may later be treated surgically when a patient deterio-
rates. The evacuation of the t-ICH can consist of removal 
of contused brain tissue. Finally, for the decision whether 
or not the evacuation of the haematoma should be 
accompanied by a DC, the surgeon weighs the increased 
complications rate of a DC against the risk of medically 
intractable diffuse brain swelling.15
High-quality evidence for these decisions (if, when 
and how) is not available. For all guidelines that relate 
to TBI, the Brain Trauma Foundation (BTF) guideline 
for surgical management of intracranial haematomas, 
devised in 2005 by an international panel of experts, is 
based solely on class III evidence.4 16 As a result these 
complex decisions are often based on intuition, regional 
training and experience of the surgeon, leading to broad 
practice variation between centres, countries and even 
between surgeons within a centre.5 17–21
Therefore, a systematic evaluation in a (prospective) 
comparative study is proposed with comprehensive 
assessment of outcome, including perceived quality of 
life. We consider an observational comparative effective-
ness design the next best alternative to a randomised 
controlled trial (RCT). These clinical questions are 
difficult to address in a randomised trial due to several 
methodological, ethical and pragmatic concerns.22 Most 
importantly, the hesitance of clinicians to randomise 
surgical treatments because of strong opinions on the 
best treatment hampers realising an RCT.
Here, we present the design of a pragmatic prospec-
tive observational cohort study of surgical strategies 
for ASDH and t-ICH, conducted in the Collaborative 
European NeuroTrauma Effectiveness Research in TBI 
(CENTER-TBI) study and the Dutch embedded complete 
chain of care Neurotraumatology Quality Registry 
(Net-QuRe).23 24
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objECtIvEs
The primary aim is to compare the effectiveness of acute 
surgery with expectant management in the treatment of 
(1) ASDH and (2) t-ICH. The secondary goal is (3) to 
assess the effectiveness of craniotomy compared with DC 
for ASDH and/or t-ICH.
MEthods And dEsIgn
design
This study uses a comparative effectiveness research 
(CER) design, a multicentre prospective observational 
cohort study that exploits variation in neurotrauma care 
to create and compare parallel study groups. The multi-
centre design is necessary to ensure the required number 
of patients with different neurotrauma treatment strat-
egies for ASDH and t-ICH. The study is conducted in 
neurosurgical trauma centres in Europe that participate 
in CENTER-TBI.23 CENTER-TBI collects data of patients 
with clinical diagnosis of TBI and an indication for a CT 
scan.25 Data for the cohort described in this protocol will 
partly be collected through CENTER-TBI. The Dutch 
centres not participating in CENTER-TBI will acquire 
data through Net-QuRe, in a separate database with a 
similar data collection protocol.24 26 The research ques-
tion and methodology described here were designed 
before the inclusion of patients.
Patient and public involvement
Patients were involved in the priority of the research ques-
tions and selection of outcome measures in a ‘patient 
advisory panel’ consisting of patients and their caregivers. 
Furthermore, some patients and their caregivers have 
been asked to join a focus group on the feasibility of the 
follow-up (burden of the follow-up, the design/length 
of the questionnaires) and to advise on other research 
questions. The patient panel and their caregivers will be 
informed about the developments of the study and will 
be invited to participate in research meetings and discus-
sions. Also, patients and family are informed of the study 
results through dedicated websites ( Center- tbi. eu and 
Net- QuRe. nl).
A public debate is going on in the Netherlands about 
whether or not patients are treated too much at an older 
age or end-of-life stage. This debate has led to the start of 
formal campaign ‘Choosing Wisely’ of which the senior 
author WPE is organising member.27 The appropriate-
ness of surgical TBI treatment has been prioritised.
Eligible study patients
The patients are selected from the observational cohorts 
from CENTER-TBI or Net-QuRe. Patients presenting to 
the emergency room with a clinical and radiological diag-
nosis of ASDH and/or a t-ICH are eligible for inclusion.
The inclusion and exclusion criteria are as following.
Inclusion criteria
 ► ASDH and/or a large (>10 cc) t-ICH on a CT-scan.
 ► Acute presentation (<24 hours of injury) with history 
of head trauma.
 ► Clinical indication for admission (ward or intensive 
care unit, ICU).
Exclusion criteria
 ► An ASDH or t-ICH due to penetrating injury, a spon-
taneous or iatrogenic ASDH/t-ICH.
 ► Severe pre-existing neurological disorder that would 
confound outcome assessments.
Patients are not excluded based on other clinical and 
radiological characteristics (such as: advanced age, anti-
platelet/anticoagulant use, small haematoma volume). 
Radiological criteria for an ASDH or t-ICH/contusion are 
a high-density lesion, with or without radiological signs 
of raised intracranial pressure (ICP) and with or without 
mass effect (ie, midline shift, compression of ventricles 
and/or basal systems). The minimal size of the t-ICH 
needs to be 10cc to be included.
Intervention procedures
Inherent to the observational design of this study the 
management strategies under investigation proceed 
according to local emergency and intensive care proto-
cols or surgeon’s expertise. Consequently, the resulting 
variation in management is accepted and analysed. To 
gain insight into this variation, detailed information 
is collected on the reasons for specific interventions or 
management strategies (see section ‘why’ questions).
Surgical strategy
Surgical treatment consists of evacuation of the haema-
toma and/or contusion with a craniotomy, or with a 
DC, defined as haematoma evacuation plus leaving a 
large portion of the skull open to allow brain swelling 
in the secondary phase, preventing subsequent brain 
injury. Generally, in Europe a craniotomy is performed 
for haematoma evacuation and DC when (intractable) 
swelling is seen intraoperatively or when swelling is 
expected (preventive). The decision for a DC can be 
made primarily, or secondarily by increasing the defect 
of the bone flap that is formed during a normal crani-
otomy. In conjunction to these surgical procedures, the 
neurosurgeon will decide to place an ICP monitor or 
not. The ICP device can be an intraparenchymal sensor 
or an external ventricular drain with a transducer for the 
ICP. The latter has an option to drain cerebrospinal fluid 
(CSF) and thereby lower ICP.
The operation will be performed by a qualified neuro-
surgeon or neurosurgical resident. The techniques 
for evacuating such haematomas are well established, 
although specific components of the operations may 
differ between surgeons. Our aim will be to collect perti-
nent operative data on a standardised data collection 
form.
The postoperative care on the ward or ICU gener-
ally is protocolised in European centres. The length of 
hospital stay will differ considerably between patients, 
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ranging from 1 day to several months, mainly related 
to the severity of the injury. The aim for a patient is to 
be discharged as soon as possible. Furthermore, the 
supportive care is provided as described in the section 
‘expectant management’.
Expectant management, with possibly delayed surgery
For patients admitted to the ward, monitoring is in 
general by clinical neurological control (GCS and motor 
strength) with or without CT brain follow-up, whereas for 
those patients admitted to the ICU (mostly severe TBI) 
the diagnostic and therapeutic options include ICP moni-
toring with medical management of intracranial hyper-
tension (ie, hyperosmolar therapies, hyperventilation, 
etc) and cerebral perfusion pressure (CPP).
Follow-up CT scans, performed during hospitalisation, 
are collected and analysed centrally, independent from 
the treating physicians. Hereby, an estimation is made 
about the proportion of the evacuated haematoma and 
the change in density of lesions.
Patients will be allocated to one of the treatment arms 
based on the initial treatment strategy. The data collec-
tion includes questions after each CT that ask whether 
or not the patient is transferred to the OR for an opera-
tive procedure. In doing so, the treatment ‘arms’ in this 
study can be carefully controlled based on the first CT on 
presentation (showing an ASDH and/or a t-ICH). The 
initial treatment regimen chosen will be one of either 
treatment arms, analysed according to an intention-to-
treat approach.
data collection
Data of care management by hospital personnel are regis-
tered in all departments. Data collection is done in a 
standardised electronic database, based on the ‘common 
data elements’ for TBI and web-based data collection 
protocol.28 29
Practice variation and provider profiling
Parallel to a survey on regional practice variation 
towards ASDH management in the Netherlands, we have 
performed provider profiling of neurosurgical care for 
TBI in Europe.18 This study provides an exploration of 
the organisation of neurosurgical care and treatment 
policy of TBI in all study centres. Such centre charac-
terisation allows specification of the local policy and 
standardised protocol. Structures and processes of care 
to be studied are patient volume, location of first Emer-
gency Room (ER) evaluation, level of the trauma centre, 
referral policy, number of neurosurgeons, type of ICU 
and 24/7 CT availability. In addition, with regard to 
postacute care, routine follow-up for ER patients, ICU 
approaches to fluid load, hyperventilation, hyperosmolar 
therapy, timing of intracranial surgery, timing of extra-
cranial surgery, glucose management, CSF drainage, 
DC, CPP management, coagulopathy treatment and ICP 
monitoring (parenchymal or CSF catheter). Whether or 
not consensus for divergent clinical decisions is agreed 
on and whether or not hospital protocols are available 
and applied.
Admission data
In short, the ‘common data elements’ entail the collec-
tion of patient characteristics including demographics, 
comorbidities, associated extracranial injuries, neuro-
logical condition, prehospital information, hypoxic and 
hypotensive periods, and CT abnormalities. For the 
purpose of CER detailed information on processes of 
care will be collected within CENTER-TBI and Net-QuRe, 
including timing (of first CT, second CT, operation), 
surgery parameters, prehospital management and Inten-
sive Care (IC) therapies (including ICP: pharmacological 
and/or DC). These data are collected on patient level, 
but also on hospital level (see paragraph ‘Practice varia-
tion and provider profiling’).
‘Why’ questions
The observational design poses a challenge for inferring 
that the surgery caused the outcome instead of other 
factors. Several known and measured confounders (pupil-
lary abnormalities, GCS and haematoma characteristics 
on CT) can be accounted for. However, for the decision 
to operate or not in intracranial haematoma, neurosur-
geons select certain clinical, radiological and subjec-
tive ‘gut feeling’ characteristics that would normally go 
unmeasured. Therefore, the following efforts are under-
taken to collect variables that normally will go unmea-
sured. To assess the effectiveness of different treatments 
for ASDH and t-ICH additional data are collected on an 
individual (doctor) level; the neurosurgeon, ICU physi-
cian and/or neurologist is asked to give their indication/
reason to choose for surgery or conservative management 
(eg, haematoma size, mass effect, clinical symptoms, clin-
ical deterioration and/or other motivation), his or her 
motivation for the chosen procedure (DC or craniotomy) 
and the anticipated prognosis of the patient.
The motivation for surgery and the prognosis is 
collected before the decision for surgery or conservative 
management because afterwards the motivation could 
have been changed due to several factors such as intra-
operative findings and the clinical course of the patient 
after the surgery.
Because of the infrastructure in TBI care, in which the 
clinician on-call is often outside the hospital and—in case 
of the neurosurgeon—will start with the surgery right 
after arrival in the hospital, the neurological and neuro-
surgical residents will assess their supervising clinician’s 
motivation before the decision is carried out. To control 
this process, the date and time of collecting these vari-
ables is collected as well.
outcome measurements and endpoints
Within CENTER-TBI and Net-QuRe, the outcome 
measures are assessed by face-to-face interviews, postal or 
emailed questionnaires or by telephone interviews at 3, 6 
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and 12 months after injury. Outcome assessment is done 
naïve for the research questions.
The primary endpoint is the 6-month Glasgow Outcome 
Score-Extended (GOSE30).
The Glasgow Outcome Scale Extended (GOSE) is the 
most commonly used outcome measure in TBI. The 
GOSE grades disability on an 8-point scale incorporating 
physical deficits as well as emotional and cognitive distur-
bances affecting disability.31 32 The GOSE is designed as 
a structured interview and can be applied through tele-
phone33 and the mail.34
Secondary endpoints are mortality, structural haema-
toma changes on CT, frequency and type of neurosurgical 
interventions, ICU and hospital length of stay (days), 
complications (hydrocephalus, intracranial haemor-
rhage, infection, pulmonary embolism, deep vein throm-
bosis and death), ‘treatment failure’ during the initial 
hospital admittance (patient in the expectant group who 
are operated at a delayed moment or patients in the early 
surgery group who are operated again), discharge to 
home (from the hospital, rehabilitation facility or nursing 
home), quality of life 6 and 12 months postinjury with 
the Short Form (SF)-12, the brain injury specific Quality 
of Life after Brain Injury Questionnaire35 and cognitive 
tests. Details of these and other outcome measures are 
provided in our previous publication.23
data analysis
Patient characteristics, hospital characteristics and vari-
ation in both treatment and outcome variation will be 
described using descriptive statistics. To assess differ-
ences between groups, appropriate tests will be employed 
according to distribution and scale of measurement 
(Student’s t-tests or Mann-Whitney U tests for continuous 
variables and X2 tests or Fisher’s exact test for categor-
ical variables). To examine effectiveness of interventions, 
proportional odds logistic regression models with the 
8-point ordinal GOSE as outcome variable will be used. 
A proportional odds model increases statistical power in 
comparison to a conventional logistic regression model 
with a binary outcome.36 The ORs derived from a propor-
tional odds regression model could be interpreted as the 
OR for shifting over the GOSE.36
The main challenge in the analyses is how to estimate 
a treatment effect in these observational data with strong 
confounding. Conventional methods, patient-level anal-
yses with covariate adjustment in regression modelling 
and propensity score matching, can insufficiently account 
for the (unmeasured) confounding in TBI.37 Therefore, 
the main analyses will use the between-hospital variation 
in treatment for determining effectiveness by comparing 
regional treatment strategies. This is an instrumental 
variable (IV) approach. The instrument is the propor-
tion of patients exposed to the intervention per hospital, 
determined as the proportion initially operated ASDH 
of total ASDH patients, initially operated t-ICH of total 
t-ICH patients and proportion of total ASDH or t-ICH 
patients exposed to primary DC (that forms a proxy for 
‘aggressiveness’ of the neurosurgical staff). Total ASDH 
and ICH numbers are available through the registry. The 
instrument is entered as an independent variable to the 
analyses. The unmeasured and measured confounding 
at the hospital level, for example, hospitals that perform 
more surgery also more often perform other treatments, 
is overcome with a multilevel analysis model.38
In this model, the random intercept should capture 
the measured and unmeasured confounders at hospital 
level, resulting in unbiased treatment effect estimates. 
The random intercept for each hospital represents the 
unexplained hospital effect (beyond all factors included 
in the model, including the instrument treatment prefer-
ence). Assumptions of the IV approach will be checked 
according to our previous published case study.37
For these analyses, hospitals contributing at least 15 
patients to the study sample are included to minimise 
the influence of chance. To increase statistical power, 
adjustment for potential patient level confounding will 
be made by adding the strongest predictors of outcome 
(age, GCS, pupillary response, CT characteristics (haema-
toma thickness and volume, subarachnoid haemorrhage, 
basal cistern compromise, other focal or diffuse lesions), 
hypoxic or hypotensive episodes and extracranial inju-
ries) as covariates.39 These factors were determined by 
prognostic modelling in the International Mission for 
Prognosis and Analysis of Clinical Trials (IMPACT) study 
based on a dataset of 10 RCTs and three observational 
studies.40 Thus, the treatment effect parameter will be 
the estimate for the effect of ‘aggressiveness’ on outcome 
from a random effects ordinal regression model with 
hospital as a random intercept.
In sensitivity analyses, the instrument validity will be 
further explored by quantifying a priori collected data, 
the results of our survey17 and the provider profiling of 
CENTER-TBI,18 and comparing these to the post hoc 
derived relative proportion exposed to the intervention 
per hospital.
In the secondary analyses, conventional regression 
modelling with covariate adjustment and propensity score 
matching is performed. In both these analyses, actual 
treatment will be a binary treatment variable and GOSE 
as ordinal outcome variable. For ASDH surgery effec-
tiveness, confounding will be controlled for by adding 
age, GCS, pupil reactivity, haematoma thickness and 
midline shift as covariates in the model. For t-ICH effec-
tiveness, confounding adjustment for age, GCS, haema-
toma volume, pupil reactivity, haematoma laterality and 
midline shift. For DC effectiveness, by age, GCS, pupil 
reactivity, midline shift and haematoma size (ASDH: 
thickness; t-ICH: volume).
Importantly, the effect of surgery is probably not 
uniform, as is suggested by empirical evidence41 42 and by 
clinical experience. Therefore, effect modification by the 
following variables will be tested using interaction terms: 
GCS of ≥9, haematoma size >10 mm in diameter, midline 
shift >5 mm, time to treatment and baseline prognostic 
risk.30
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sample size
In CENTER-TBI and Net-QuRe together approximately 
1000 patients with ASDH are expected. For t-ICH, 750 
patients are expected. Parallel to the core study, 3500 and 
3000 ASDH and ICH patients are expected in the registry, 
respectively. These patients are recruited in approxi-
mately 70 centres.
Standard sample size calculations for these specific 
analyses are not readily available. Therefore, a simulation 
study was performed to calculate statistical power. The 
assumptions for these calculations were the following: 
30, 50 or 70 hospitals, variation of intracranial operation 
among hospitals 10%–90% and an effect estimate of OR 
0.6 on unfavourable outcome. In addition, we assumed 
covariate adjustment and the ordinal analysis to increase 
power with 40%–49%.36 The simulation confirmed these 
sample sizes to be sufficient to obtain a power of 80% to 
detect a difference (assuming a two-sided significance 
0.05).
This is in line with preparatory simulation study we 
performed in which a true treatment effect was simulated 
specifically to assess the TBI specific associations between 
covariates and outcome.37 This simulation study was built 
around the International and North American Tirilazad 
trial dataset (86 hospitals between 1992 and 1994) of the 
IMPACT dataset,40 which was inflated to CENTER-TBI/
Net-QuRe numbers (respectively, 750 and 1000 patients 
from 70 hospitals). We simulated a hypothetical inter-
vention with an OR 1.5. For the association between the 
hypothetical intervention and confounders, we used 
the observed associations between intracranial opera-
tion and confounders in the Tirilazad dataset. We used 
6-month binary (functional) outcome as dependent vari-
able, which was generated based on a combination of the 
prognostic effect of the confounders and the effect of the 
hypothetical intervention.
For analyses and simulations R statistical software with 
add ons (the rms and lme4 packages) is used.
Missing data
Missing baseline data will be imputed with multiple impu-
tation (n=5).
reporting
Reporting of our study will follow the Strengthening 
the Reporting of Observational Studies in Epidemi-
ology statement with a special focus on IV analyses 
recommendations.43
study limitations
The main limitation of this study is the absence of a 
randomised assignment of treatment or strategy. Risks 
of confounding by indication are reduced by IV analysis. 
The success of the primary analysis, however, depends 
on the strength of the instrument, that is, the difference 
in aggressive versus conservative practice style between 
physicians during the study period. The results of the 
provider profiling (before the study) are encouraging. 
As secondary analyses, we perform more conventional 
approaches to adjust for confounding by indication 
(multivariable adjustment and propensity scores). The 
results of analytical approaches will be interpreted in 
the light of the assumptions they require and to what 
extent these are likely to be fulfilled in the data. The final 
conclusion will be drawn based on the joint results of all 
analyses.
dIsCussIon
There is controversy with regard to the initial neurosur-
gical management of ASDH and t-ICH. First, neurosur-
geons are faced with an acute decision to operate or not, 
and second, are confronted by the choice to evacuate the 
haematoma with or without a DC. The complexity lies in 
the balance between too liberal surgical indications with 
an increased number of survivors with severe disabilities 
against inappropriate conservative management with 
unnecessary death and disability. In combination with the 
circumstances, that is, urgency and time pressure as well 
as absence of peer consultation, these treatment decisions 
have been shown to lead to variation in surgical treatment 
between surgeons.
The proposed study will provide a strong level of 
evidence for surgical management of ASDH and t-ICH. 
We expect that the large natural existing practice variation 
in management of these intracranial lesions17 18 could in 
part explain the unexplained between-centre variability 
in outcome in TBI.44 Thereby, the impact on patients will 
probably be significant. Recognising and implementing 
the most effective clinical treatment strategy could be 
an important step towards reducing the widely differing 
injury mortality rates across Europe.45
Current and ongoing studies are sparse. Since the 
BTF guideline, which was based on merely retrospective 
studies with small or selected study populations that were 
performed more than 10 years before the guideline,5 10 11 46 
there have been only some comparative studies. In our 
own retrospective analyses, early ASDH evacuation might 
be associated with lower odds of mortality and unfavour-
able outcome (GOS ≦3).41 This is the first report showing 
an effect estimate of surgery for ASDH. The clinical effec-
tiveness of an early evacuation for t-ICH was challenged 
in the Surgical Trial in Traumatic Intracerebral Haemor-
rhage Trauma, an international multicentre pragmatic 
RCT.47 The study started in October 2009 but was halted 
due to a disbalance in recruited patients per country. 
In the analysis of the included patients, a strong (but 
non-significant) tendency towards benefit of early surgery 
was found on the primary endpoint the dichotomous 
GOS and there were significantly more deaths in the 
initial conservative treatment group. The effectiveness of 
a primary DC in patients with ASDH is currently being 
assessed in the recruiting RESCUE-ASDH randomised 
trial.15
Thus, these traumatic haematomas confront the neuro-
surgeon with a challenging surgical decision-making task, 
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which, most likely due to a lack of general evidence, leads 
to broad variation in current surgical practice patterns. 
While RCTs can be delivered and provide high level 
evidence, they are challenging to conduct, hence the 
rationale for other methodological intervention para-
digms. The high-quality observational study presented in 
this article, with a focus on the analysis of the differences 
in management and outcome, is expected to provide the 
much-needed further evidence in the field of surgical 
management of traumatic focal lesions.
Ethics and dissemination
Written informed consent is obtained from the patient or 
the legal first representative on the ER and preferably as 
soon as possible. Center-TBI is registered at  ClinicalTrials. 
gov (NCT02210221) and Net-QuRe is registered at the 
Netherlands Trial Register (NL5761).25 26
Results of surgical management of ASDH and t-ICH will 
separately be submitted for publication in apeer-reviewed 
journal. The completion dates of CENTER-TBI and 
Net-QuRe are 1 April 2020 and 1 July 2022, respectively.
The data that support the findings of this study are avail-
able but restrictions apply to the availability of these data, 
which were used under licence for the current study, and 
so are not publicly available. Data are, however, available 
from the authors on reasonable request, with permission 
of the CENTER-TBI and Net-QuRe management teams.
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